Key result
Cardiac magnetic resonance is the gold standard non-invasive imaging modality to phenotype cardiovascular complications after COVID-19.
Why the study?
Cardiovascular involvement following COVID-19 is heterogeneous, prevalent, and often missed by echocardiography and serum biomarkers, making non-invasive phenotyping with CMR important in evaluating complications.
This review highlights the utility of cardiac magnetic resonance as the gold standard non-invasive imaging modality for phenotyping cardiovascular involvement following COVID-19.
CMR may guide targeted post-COVID cardiac evaluation; leaves open prospective outcome trials before routine adoption.
Cardiovascular involvement following COVID-19 is heterogeneous, prevalent and is often missed by echocardiography and serum biomarkers (such as troponin I and brain natriuretic peptide). Cardiac magnetic resonance (CMR) is the gold standard non-invasive imaging modality to phenotype unique populations after COVID-19, such as competitive athletes with a heightened risk of sudden cardiac death, patients with multisystem inflammatory syndrome, and people suspected of having COVID-19 vaccine-induced myocarditis. This review summarises the key attributes of CMR, reviews the literature that has emerged for using CMR for people who may have COVID-19-related complications after COVID-19, and offers expert opinion regarding future avenues of investigation and the importance of reporting findings.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2022) conducted a review in COVID-19 cardiovascular involvement. Cardiac magnetic resonance (CMR) was evaluated. Cardiac magnetic resonance is the gold standard non-invasive imaging modality to phenotype cardiovascular complications after COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: